Microsoft is testing a new taskbar icon scaling feature that automatically scales down Windows taskbar icons to show more apps when it gets too overcrowded. The feature is gradually rolling out ...

British self-driving technology startup Wayve said on Tuesday it has established a new testing and development centre in Japan, its first expansion into an Asian market. Wayve said the new centre ...

A research team is developing a 3D-printed skin imitation equipped with living cells in order to test nanoparticles from cosmetics without animal testing. A research team from TU Graz and the ...

Though once a common practice, it has faced fierce backlash from animal welfare organizations, who argue that animal testing is unnecessarily cruel. At least 44 countries and 12 U.S. states have ...

While we're making progress in phasing out animal testing in the cosmetics industry around the world, there's still a ways to go in terms of regulatory measures (some 35 US states still allow it ...

And currently, before they can test a new therapy in humans, they must show proof that it worked in a lab and often that it works in animals. For decades, animals have been a key to biomedical ...

The KTM 390 SMC R, snapped testing suggests that it is inspired by the Enduro R KTM is in full swing with its range of new motorcycles in India. KTM has slated the 390 Enduro R for its official ...

Microsoft has started testing a new update to its Copilot app on Windows that will let you share your screen or apps with the AI assistant. Copilot Vision was originally limited to Microsoft’s ...

Get Instant Summarized Text (Gist) 3D-printed skin imitations, developed using hydrogel formulations with living cells, offer a promising alternative to animal testing for cosmetics. These ...

Welcome to The Protocol, CoinDesk's weekly wrap-up of the most important stories in cryptocurrency tech development. I'm Ben Schiller.

The final dress rehearsal for Ethereum’s upcoming Pectra upgrade occurred Wednesday, as the blockchain's biggest changes in over a year were tested an additional time following a series of mishaps.

Pfizer Ends Testing of Obesity Pill After Possible Liver Injury TUESDAY, April 15, 2025 (HealthDay News) -- Pfizer has stopped developing a once-daily pill to treat obesity after a person in a ...